Following the first case of Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-Cov-2), in Wuhan, China, in December 2019, it has spread worldwide. An outbreak in Japan occurred on a cruise ship, and this was followed by community-acquired COVID-19. Herein, we report three cases of COVID-19 that presented pneumonia following admission to Kitasato University Hospital. Patients were admitted based on the positive result of real-time reverse transcriptase–polymerase chain reaction (RT-PCR) tests for COVID-19 nucleic acid. All patients were diagnosed as suffering from non-severe COVID-19 pneumonia and were successfully treated with Lopinavir/Ritonavir (LPV/r). LPV/r could be an option for treating non-severe COVID-19 pneumonia in general and even in elderly patients.
【저자키워드】 COVID-19, hyponatremia, Lopinavir, Ritonavir, Elderly patient, Cruise ship, 【초록키워드】 Lopinavir/ritonavir, Pneumonia, elderly patients, RT-PCR, Spread, nucleic acid, outbreak, Patient, Japan, respiratory, university, Admission, positive result, Wuhan, China, occurred, caused, diagnosed, treated, 【제목키워드】 Lopinavir/ritonavir, novel,